Why Is Medpace (MEDP) Up 1.1% Since Last Earnings Report?

Medpace (MEDP) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • 18 hours ago

Medpace (MEDP) is an Incredible Growth Stock: 3 Reasons Why

Medpace (MEDP) possesses solid growth attributes, which could help it handily outperform the market.

Zacks Investment Research • Aug 18, 2026

Kuehn Law Encourages Investors of Medpace Holdings, Inc. to Contact Law Firm

NEW YORK, Aug. 10, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Medpace Holdings, Inc. (NASDAQ: MEDP)  breached their fiduciary duties to shareholders.  According to a federal securities lawsuit, Medpace Holdings misrepresented or failed to disclose material information concerning the Company's backlog cancellation rates, business conditions, and ability to maintain its projected 1.15 book-to-bill ratio.

PRNewsWire • Aug 10, 2026

Here's Why Medpace (MEDP) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Aug 10, 2026

CON or MEDP: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical Services sector have probably already heard of Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • Aug 10, 2026

Medpace (MEDP) Just Flashed Golden Cross Signal: Do You Buy?

Medpace Holdings, Inc. (MEDP) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, MEDP's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.

Zacks Investment Research • Aug 7, 2026

Is MEDP Worth Buying as Growth Collides With a Premium Valuation?

Medpace pairs double-digit growth, record awards and a strong balance sheet with a rich valuation, raising the question of whether the premium already prices in its outlook.

Zacks Investment Research • Aug 6, 2026

Can MEDP's Record Q2 Bookings Build a Stronger Growth Path for 2027?

Medpace Holdings, Inc.  MEDP regained commercial momentum in the second quarter of 2026 as record awards and a higher book-to-bill ratio reversed the weaker first-quarter trend.

Zacks Investment Research • Aug 5, 2026

Why Medpace (MEDP) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Aug 3, 2026

3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP)

Medpace (MEDP) could produce exceptional returns because of its solid growth attributes.

Zacks Investment Research • Jul 27, 2026